BMT - bone marrow transplant
Showing 1 - 25 of >10,000
Bone Marrow Transplantation, Bone Marrow Disease Trial in Chapel Hill (physical and occupational therapy consultation)
Not yet recruiting
- Bone Marrow Transplantation
- Bone Marrow Disease
- physical and occupational therapy consultation
-
Chapel Hill, North CarolinaLineberger Comphrehensive Cancer Center at University of North C
Aug 4, 2023
Bone Marrow Transplant Complications Trial in Boston (BMT-VR)
Recruiting
- Bone Marrow Transplant Complications
- BMT-VR
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)
Recruiting
- Sickle Cell Disease
- Bone Marrow Transplant (BMT)
- +7 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Sep 13, 2022
Leukemia Trial in Aurora (BioIntelliSense BioButton Rechargable, Memora Health two-way patient engagement platform provided by
Recruiting
- Leukemia
- BioIntelliSense BioButton Rechargable
- Memora Health two-way patient engagement platform provided by RC
-
Aurora, ColoradoUniversity of Colorado Hospital
Apr 20, 2023
Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)
Completed
- Sickle Cell Disease
- Hematopoietic Stem Cell Transplantation
-
Birmingham, Alabama
- +18 more
Dec 7, 2022
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia
- +12 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Dec 13, 2022
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,
Recruiting
- Severe Sickle Cell Disease
- +5 more
- RIC regimen
- GVHD prophylaxis regimen
-
New Haven, Connecticut
- +1 more
Feb 4, 2022
Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)
Active, not recruiting
- Primary Immunodeficiency
- PID
- CD3/CD19 neg allogeneic BMT
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of University of Pittsburgh Me
Oct 6, 2021
Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow
Available
- Benign Neoplasm
- +3 more
- Bone Marrow Transplantation
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 9, 2021
Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,
Completed
- Myeloablative Conditioning
- +3 more
- Cyclophosphamide
- +5 more
-
Aurora, Colorado
- +8 more
Nov 23, 2021
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bone Marrow Hematopoeitic Cell Transplant (HCT)
- +9 more
- (no location specified)
Sep 27, 2021
Bone Marrow Transplantation Trial in Lexington (BMT Physical Activity app, Watch Only)
Recruiting
- Bone Marrow Transplantation
- BMT Physical Activity app
- Watch Only
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Apr 26, 2021
Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)
Active, not recruiting
- Sickle Cell Disease
- Busulfan
- +11 more
-
Oakland, California
- +34 more
Sep 21, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid
Recruiting
- Previously Treated Myelodysplastic Syndrome
- +3 more
- Fludarabine Phosphate
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 7, 2022
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)
Completed
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Bone Marrow Transplantation
- +2 more
-
Baltimore, Maryland
- +1 more
May 27, 2021
Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with
Recruiting
- Bone Marrow Failure Syndromes
- MRD-BMT with Fludarabine-based RIC for Acquired AA
- +2 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
May 6, 2022
Bone Marrow Transplant Trial in Aurora (BioIntellisense BioSticker)
Completed
- Bone Marrow Transplant
- BioIntellisense BioSticker
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 14, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Total-Body Irradiation
- +8 more
-
Los Angeles, California
- +9 more
Aug 19, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia in Remission
- +11 more
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 24, 2022
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022